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ABSTRACT 
Totaro} is a diterpene isolated in large quantities from P. totara and a range of other 
plants, that has been shown to possess significant antibacterial activity against Gram 
positive bacteria. It has not been possible to unequivocally determine the mode of 
action by which this activity occurs. This research aimed to determine the mode of 
action of the diterpene and study a range of derivatives to elucidate a structure-
function relationship for the diterpene to enable directional synthesis of future 
derivatives possessing increased activity and bioavailability. 
The antibacterial activity of totarol and 29 derivatives was tested against H pylori 
and S. aureus, two significant human pathogens, as representative Gram negative and 
Gram positive bacteria. Four compounds were found to possess significant activity 
against S. aureus, both MRSA and MSSA, although no significant activity was 
observed against H pylori. The ability of the derivatives to potentiate the activity 
of existing ~-lactam antibiotics such as methicillin was also investigated for MRSA 
and E. co/i. Seven compounds including totarol were found to potentiate methicillin, 
one 256-fold, although no potentiation activity was exhibited against E .coli. 
The incorporation of radiolabelled precursors was used to investigate the effect of 
totarol on the synthesis of three macromolecules, DNA, protein and peptidoglycan, in 
MRSA. No primary inhibition was detected, indicating that the mode of action of the 
diterpene was not inhibition of synthesis of any of these macromolecules. 
The effect of totarol on the cellular respiration of MRSA was also investigated, 
showing 70 % inhibition of respiration at MIC levels, and complete inhibition of 
respiration at five times that concentration. It was therefore concluded that this was 
the most likely primary antibacterial effect of the compound. 
The effect of totarol on the production of PBP 2a, an important protein in the ~-
lactam resistance mechanism of MRSA, was also investigated using a novel, non-
radioactive labelling procedure to detect the protein. However, although a variety of 
ii 
strategies were employed to detect the protein, none were successful, and the 
experiment set aside until the arrival of anti-PBP 2a antibody for use in another 
strategy. 
Future work on this project that could be undertaken includes determination of the 
effect of the derivatives on cellular respiration under potentiation conditions, 
determination of the component(s) of the respiratory chain affected by totarol, and 
the investigation of the effect of the diterpene on PBP 2a production and function 
using antibody to detect the protein. 
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